Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01166763 · ClinicalTrials.gov registry record · NA
Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D
A NA study, sponsored by Carol Fabian, MD.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT01166763 is a NA study that has completed, run by Carol Fabian, MD. The registered enrollment target is 30 participants.
The verdict
NCT01166763, a NA study, has completed, sponsored by Carol Fabian, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The overall goal of this project is to determine if high dose vitamin D3 given to premenopausal women at high risk for development of breast cancer, who initially have insufficient levels of 25-hydroxy vitamin D (\<30 ng/ml), will raise 25(OH)D levels above 50 ng/ml. If so, will certain risk biomarkers for development of breast cancer be reliably and favorably modulated?
Interventions
- DRUG vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01166763
The ClinicalTrials.gov registry entry for NCT01166763 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carol Fabian, MD, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which vitamin D3 is the first listed.
NCT01166763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01166763 about?
NCT01166763 is a clinical study titled "Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D". The overall goal of this project is to determine if high dose vitamin D3 given to premenopausal women at high risk for development of breast cancer, who initially have insufficient levels of 25-hydroxy vitamin D (\<30 ng/ml), will raise 25(OH)D levels above 50 ng/ml. If so, will certain risk biomark...
What is the current status of trial NCT01166763?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2009-05. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01166763?
The interventions under investigation include: vitamin D3 (DRUG).
Who is sponsoring clinical trial NCT01166763?
This trial is sponsored by Carol Fabian, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.